Herpetrione, a New Type of PPARα Ligand as a Therapeutic Strategy Against Nonalcoholic Steatohepatitis

Non-alcoholic fatty liver disease, especially nonalcoholic steatohepatitis (NASH), is a leading cause of cirrhosis and liver cancer worldwide; nevertheless, there are no Food and Drug Administration-approved drugs for treating NASH until now. Peroxisome proliferator-activated receptor alpha (PPARα)...

Descripción completa

Detalles Bibliográficos
Autores principales: Linghu, Lang, Zong, Wei, Liao, Yixuan, Chen, Qianyu, Meng, Fancheng, Wang, Guowei, Liao, Zhihua, Lan, Xiaozhong, Chen, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AAAS 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687582/
https://www.ncbi.nlm.nih.gov/pubmed/38034083
http://dx.doi.org/10.34133/research.0276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687582/
https://www.ncbi.nlm.nih.gov/pubmed/38034083
http://dx.doi.org/10.34133/research.0276

Ejemplares similares